Who owns Lexicon Pharmaceuticals?

Key details on Lexicon Pharmaceuticals (Ticker: LXRX)

Who owns Lexicon Pharmaceuticals?

Is LXRX a good stock to own? Find out who bought Lexicon Pharmaceuticals, who sold Lexicon Pharmaceuticals (LXRX) stock, and who holds a large position in Lexicon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
Artal Group S.A. 253.37M $357.25M Sept. 30, 2014
FMR 77.22M $108.88M Sept. 30, 2014
Ulys 29.78M $41.99M Sept. 30, 2014
UBS GLOBAL ASSET MANAGEMENT AMERICAS 23.48M $33.34M Sept. 30, 2014
Vanguard 14.74M $20.78M Sept. 30, 2014
NEA Management Company 11.68M $16.46M Sept. 30, 2014
BlackRock Fund Advisors 11.19M $15.78M Sept. 30, 2014
BlackRock Institutional Trust Company, N.A. 7.35M $10.37M Sept. 30, 2014
T. Rowe Price Associates 6.12M $9.86M June 30, 2014
Invus Public Equities Advisors 3.89M $6.85M June 30, 2011
STATE STREET CORPORATION 3.63M $5.11M Sept. 30, 2014
Perceptive Advisors 3.20M $6.97M March 31, 2013
Schroder Investment Management 3.05M $4.29M Sept. 30, 2014
NORTHERN TRUST 2.96M $5.12M March 31, 2014
JPMORGAN CHASE & CO 2.92M $6.57M June 30, 2012
Franklin Resources 2.76M $6.00M June 30, 2013
Royce & Associates 2.74M $3.86M Sept. 30, 2014
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 2.59M $3.66M Sept. 30, 2014